INTEGRUM AB B
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoidi… Read more
INTEGRUM AB B (6Y1) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, INTEGRUM AB B (6Y1) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
INTEGRUM AB B - Net Assets Trend (None–None)
This chart illustrates how INTEGRUM AB B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INTEGRUM AB B (None–None)
The table below shows the annual net assets of INTEGRUM AB B from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to INTEGRUM AB B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
INTEGRUM AB B Competitors by Market Cap
The table below lists competitors of INTEGRUM AB B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Agillic A/S
CO:AGILC
|
$10.22 Million |
|
Long An Food Processing Export JSC
VN:LAF
|
$10.22 Million |
|
Dali Pharmaceutical Co Ltd
SHG:603963
|
$10.22 Million |
|
Helios Energy Ltd
AU:HE8
|
$10.23 Million |
|
HANHUA FNCL HLDG CO.H YC1
F:5HF
|
$10.21 Million |
|
Aqua Corporation Public Company Limited
BK:AQUA
|
$10.21 Million |
|
Andromeda Metals Limited
PINK:ANDMF
|
$10.20 Million |
|
AIM Commercial Growth Freehold And Leasehold Real Estate Investment Trust
BK:AIMCG
|
$10.20 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INTEGRUM AB B's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares INTEGRUM AB B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently INTEGRUM AB B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares INTEGRUM AB B's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INTEGRUM AB B (6Y1) | €- | N/A | N/A | $10.21 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.30 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $42.41 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.72 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $620.14 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.29 Million |